The efficacy and safety of levofloxacin 750 mg (Hileflox) in the treatment of chronic prostatitis

The efficacy and safety of levofloxacin 750 mg (Hileflox) in the treatment of chronic prostatitis

Show other versions (1)

Chronic prostatitis is the most common urological disease in men aged 20 to 50 years. Chronic bacterial prostatitis occurs in 5–10 % of cases.The aim of the study was to determine the efficacy and safety of Hileflox (levofloxacin) in chronic bacterial prostatitis in a dosage of 750 mg per day for 10...

Full description

Bibliographic Details
Main Authors:	L. A. Logvinov, K. V. Kumachev, I. V. Vinogradov, L. M. Vinogradova, M. Yu. Gabliya, E. S. Dendeberov
Format:	Article
Language:	Russian
Published:	ABV-press 2014-11-01
Series:	Андрология и генитальная хирургия
Subjects:	chronic bacterial prostatitis levofloxacin antimicrobial treatment
Online Access:	https://agx.abvpress.ru/jour/article/view/32

Similar Items

The efficacy and safety of levofloxacin 750 mg (Hileflox) in the treatment of chronic prostatitis
by: L. A. Logvinov, et al.
Published: (2014-11-01)

An observational study to monitor the efficacy and tolerability of levofloxacin 500 mg once daily for treatment of chronic bacterial prostatitis in Saudi Arabia
by: Amr Ismail El Meliegy, et al.
Published: (2015-01-01)

Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients
by: Tommaso Cai, et al.
Published: (2016-10-01)

Levofloxacin efficacy in current surgical practice
by: O A Nazarchuk, et al.
Published: (2021-03-01)

Efficacy of prostate extract in the treatment of patients with chronic prostatitis caused by intracellular pathogens
by: K. V. Kumachev, et al.
Published: (2019-08-01)

A Case of Listeria monocytogenes Bacteremia Treated with Levofloxacin
by: Ferit ÇELİK, et al.
Published: (2014-12-01)

Molecular and proteomic analysis of levofloxacin and metronidazole resistant Helicobacter pylori
by: Aimi Hanafi, et al.
Published: (2016-12-01)

Severe shoulder tendinopathy associated with levofloxacin
by: Walter de Araujo Eyer-Silva, et al.

Role and place of levofloxacin in the treatment of community-acquired pneumonia
by: D V Dmytriiev, et al.
Published: (2021-03-01)

Optimized Preparation of Levofloxacin Loaded Polymeric Nanoparticles
by: Manuel López-López, et al.
Published: (2019-01-01)

Effect of levofloxacin on some body tissues in mice
by: Rand A. Abdullah, et al.
Published: (2021-01-01)

Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity
by: Rabia Hayee, et al.
Published: (2024-05-01)

Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid
by: Masashi Nishikubo, et al.
Published: (2019-06-01)

Covalent modification of a ten-residue cationic antimicrobial peptide with levofloxacin
by: Carlos Alberto Rodriguez, et al.
Published: (2014-09-01)

The Study of Effect of Levofloxacin on Disorders of Female Hormones in Rats
by: Mehdi Ahmadifar, et al.
Published: (2014-05-01)

Intracranial hypertension secondary to levofloxacin-therapy
by: Jamir Pitton Rissardo, et al.
Published: (2019-01-01)

Adsorption of Levofloxacin on Microplastics in Aqueous Solution
by: Jooyoung Lee, et al.
Published: (2022-06-01)

Investigation of In-ovo cytogenetic effect of Levofloxacin
by: Marwa H. N.
Published: (2018-02-01)

Levofloxacin Induced Stomatitis: A Case Report
by: Atousa Hakamifard, et al.
Published: (2019-08-01)

A retrospective study of the efficacy and safety of levofloxacin in children with severe infection
by: Zhang Junqi, et al.
Published: (2024-04-01)

Comparative Study of the clinical effects of Levofloxacin and Spiramycin on induced colibacellosis in chicken
by: Shatha mousa mlaghee Al Safi, et al.
Published: (2017-12-01)

Ester Prodrugs of Levofloxacin to Prevent Chelate Formation in Presence of Aluminium Ion
by: Yorinobu Maeda, et al.
Published: (2023-01-01)

The effect of levofloxacin ointment against imiquimod induced–psoriasis in mice model
by: Waleed K. Al-Bahadly, et al.
Published: (2023-10-01)

Levofloxacin-Induced Fatal Hypoglycaemia in a Non-Diabetic Patient: A Case Report
by: Yash N Panchal, et al.
Published: (2023-09-01)

Amphotericin B- and Levofloxacin-Loaded Chitosan Films for Potential Use in Antimicrobial Wound Dressings: Analytical Method Development and Its Application
by: Ke Peng, et al.
Published: (2022-11-01)

New Organic Salt from Levofloxacin-Citric Acid: What Is the Impact on the Stability and Antibiotic Potency?
by: Ilma Nugrahani, et al.
Published: (2022-03-01)

Ratio - First Order Derivative - Zero Crossing UV-Visible Spectrophotometric Method for Analysis of Amoxicillin, Levofloxacin and Lansoprazole Mixture
by: Mustafa Gülfen, et al.
Published: (2020-06-01)

Fabrication of levofloxacin-loaded porcine acellular dermal matrix hydrogel and functional assessment in urinary tract infection
by: Yi Yang, et al.
Published: (2024-02-01)

Levofloxacin versus ceftriaxone and azithromycin for treating community-acquired pneumonia: a randomized clinical trial study
by: Davood Yadegarynia, et al.
Published: (2022-08-01)

Levofloxacin Cocrystal/Salt with Phthalimide and Caffeic Acid as Promising Solid-State Approach to Improve Antimicrobial Efficiency
by: Noor Ul Islam, et al.
Published: (2022-06-01)

Combined System for the Simultaneous Delivery of Levofloxacin and Rifampicin: Structural and Functional Properties and Antibacterial Activity
by: Irina M. Le-Deygen, et al.
Published: (2023-07-01)

Levofloxacin: role and place in the treatment of infections of the lower respiratorytracts
by: A I Sinopalnikov, et al.
Published: (2004-11-01)

Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections
by: Eliana S. Armstrong, et al.
Published: (2016-11-01)

Analysis of curative effect and drug tolerance in the treatment of severe bacterial oculopathy by levofloxacin
by: Su-Hua Xiao
Published: (2014-09-01)

Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
by: Ramirez Julio A, et al.
Published: (2012-07-01)

Treatment of Listeria monocytogenes bacteremia with oral levofloxacin in an immunocompromised patient
by: Yo Ishihara, et al.
Published: (2023-01-01)

Synthesis of Stable Isotope Deuterium Labeled Levofloxacin-D3
by: XU Zhong jie;ZHANG Li;SUN Wen;ZHANG Pengshuai;LEI Wen
Published: (2023-02-01)

Synergistic Effects of Anionic/Cationic Dendrimers and Levofloxacin on Antibacterial Activities
by: Natalia Wrońska, et al.
Published: (2019-08-01)

Cyclodextrins and Their Polymers Affect the Lipid Membrane Permeability and Increase Levofloxacin’s Antibacterial Activity In Vitro
by: Anna A. Skuredina, et al.
Published: (2022-10-01)

Design and characterization of nanocarriers loaded with Levofloxacin for enhanced antimicrobial activity; physicochemical properties, in vitro release and oral acute toxicity
by: Panoraia Siafaka, et al.